title: [Recurrent dysphonia: adverse drug reaction of adalimumab?].
authors.forename: Marie-Amélie
authors.initials: MA
authors.lastname: Segard
authors.forename: Thomas
authors.initials: T
authors.lastname: Bancourt
authors.forename: Patrick
authors.initials: P
authors.lastname: Coupé
authors.forename: Arnaud
authors.initials: A
authors.lastname: Boruchowicz
authors.forename: Nathalie
authors.initials: N
authors.lastname: Massy
authors.forename: Sophie
authors.initials: S
authors.lastname: Gautier
mesh_terms: D000068879:Adalimumab; D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D002180:Candidiasis, Oral / Q000175:diagnosis; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy; D003937:Diagnosis, Differential; D055154:Dysphonia / Q000139:chemically induced* / Q000209:etiology; D016145:Endoscopy, Digestive System; D005260:Female; D005764:Gastroesophageal Reflux / Q000175:diagnosis; D006801:Humans; D006984:Hypertrophy; D007827:Laryngitis / Q000139:chemically induced* / Q000150:complications; D007971:Leukoplakia / Q000175:diagnosis; D014066:Palatine Tonsil / Q000473:pathology; D010612:Pharyngitis / Q000139:chemically induced* / Q000150:complications; D012008:Recurrence; D014059:Tongue; D014827:Vocal Cords / Q000473:pathology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab